{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:32:21Z","timestamp":1778657541140,"version":"3.51.4"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T00:00:00Z","timestamp":1128384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> This study aimed to evaluate the outcome following myeloablative allogeneic hematopoietic stem cell transplantation (SCT) among patients older than 50\u2003yr of age. A total of 215 patients with a median age of 57\u2003yr underwent allogeneic hematopoietic SCT for early (41%) or advanced (59%) hematologic malignancies. After a median follow\u2010up of 36\u2003months a 10\u2010yr survival estimate of 56\u2003\u00b1\u20036% could be assessed for patients in early disease stages while patients with advanced diseases showed a significantly decreased survival probability of 31\u2003\u00b1\u20035% (p\u2003&lt;\u20030.0002). Transplant related mortality (TRM) at day 100 and 365 post\u2010transplant was 13% and 30% for early but increased to 21% and 49% for advanced disease stages. As major determinants of TRM advanced disease stage (p\u2003&lt;\u20030.0001) and occurrence of grades II\u2013IV graft\u2010vs.\u2010host disease (GVHD) (p\u2003&lt;\u20030.0001) were identified. These results show that hematopoietic SCT following myeloablative conditioning is also applicable to elderly patients whereas disease stage and high\u2010grade GVHD represent the essential prognostic factors for outcome.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2005.00453.x","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T15:38:38Z","timestamp":1128440318000},"page":"127-131","source":"Crossref","is-referenced-by-count":20,"title":["Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients"],"prefix":"10.1111","volume":"20","author":[{"given":"M","family":"Ditschkowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AH","family":"Elmaagacli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Trenschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NK","family":"Steckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Koldehoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DW","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,4]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704518"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V67.3.770.770","article-title":"Bone marrow transplantation in patients aged 45\u2003years and older","volume":"67","author":"Klingemann H\u2010G","year":"1986","journal-title":"Blood"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.10.1489"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.3.756"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2866"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21979"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1615"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704435"},{"key":"e_1_2_5_10_2","first-page":"965","article-title":"Allogeneic hematopoietic stem cell transplantation in patients 50\u2003years of age and older","volume":"87","author":"De la Camara R","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_5_11_2","first-page":"S86","article-title":"Allotransplantation of haematopoietic stem cells for early stage leukaemia in patients aged 40\u2003years or more: overall survival improves significantly if a younger unrelated donor is preferred over an older sibling donor","volume":"35","author":"Ottinger H","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.09.110"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403591"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704540"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704379"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0545"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2005.00453.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:34:26Z","timestamp":1696919666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2005.00453.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1399-0012.2005.00453.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2005.00453.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,4]]}}}